Embecta Corp. (NASDAQ:EMBC) Plans Quarterly Dividend of $0.15

Embecta Corp. (NASDAQ:EMBC) declared a quarterly dividend on Tuesday, November 25th. Stockholders of record on Friday, December 5th will be paid a dividend of 0.15 per share on Thursday, December 18th. This represents a c) annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Friday, December 5th.

Embecta has a payout ratio of 21.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Embecta to earn $3.07 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 19.5%.

Embecta Trading Down 7.2%

EMBC traded down $1.06 on Tuesday, hitting $13.58. 1,136,194 shares of the company’s stock traded hands, compared to its average volume of 554,458. The company’s 50 day simple moving average is $14.08 and its 200-day simple moving average is $12.47. Embecta has a one year low of $9.20 and a one year high of $21.48. The firm has a market cap of $794.29 million, a price-to-earnings ratio of 9.50, a P/E/G ratio of 0.81 and a beta of 1.10.

Embecta (NASDAQ:EMBC) last announced its quarterly earnings data on Tuesday, November 25th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.04. Embecta had a net margin of 7.58% and a negative return on equity of 23.40%. The business had revenue of $263.30 million during the quarter, compared to analyst estimates of $265.66 million. During the same period last year, the firm posted $0.45 EPS. The company’s revenue was down 7.7% on a year-over-year basis. Embecta has set its FY 2026 guidance at 2.800-3.000 EPS. As a group, equities analysts anticipate that Embecta will post 2.85 EPS for the current fiscal year.

Institutional Trading of Embecta

Institutional investors have recently added to or reduced their stakes in the company. Larson Financial Group LLC lifted its holdings in Embecta by 368.6% during the 3rd quarter. Larson Financial Group LLC now owns 2,001 shares of the company’s stock valued at $28,000 after buying an additional 1,574 shares in the last quarter. Banque Transatlantique SA grew its stake in Embecta by 879.1% during the 1st quarter. Banque Transatlantique SA now owns 3,701 shares of the company’s stock worth $44,000 after buying an additional 3,323 shares during the last quarter. Brooklyn Investment Group raised its position in shares of Embecta by 1,164.1% in the 1st quarter. Brooklyn Investment Group now owns 3,590 shares of the company’s stock valued at $46,000 after purchasing an additional 3,306 shares during the last quarter. Wealthquest Corp purchased a new stake in shares of Embecta during the first quarter valued at $48,000. Finally, Picton Mahoney Asset Management acquired a new position in shares of Embecta in the first quarter valued at about $50,000. Institutional investors own 93.83% of the company’s stock.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.